Specialty Pharmacy

Dolutegravir-based treatment non-inferior to boosted protease inhibitor regimen in virally suppressed HIV-positive patients.

Investigators compare long-term overall and disease-free survival rates in neoadjuvant versus adjuvant radiotherapy.

Top news of the day from across the health care landscape.

Global market for HER2-positive breast cancer to increase to $9.89 billion in 2025.

A diet high in red and processed meats, sugar, and saturated fats can lead to colorectal cancer.

The FDA is requesting a new clinical study before evaluating a new drug application for baricitinib, an oral medication for moderate-to-severe rheumatoid arthritis.

The future for pharmacy is very lucrative as they press on for provider status.

Fixed-dose combination tablet containing doravirine achieved viral suppression in HIV-1 infected treatment-naïve adults.

Immunization of cows induces rapid elicitation of broadly neutralizing antibodies to HIV.

Novel approach may improve efficacy of pancreatic cancer treatments.

Breast microbiome may be harnessed to treat the development of breast cancer.

Tools that analyze the cancer genome provide new insight into the mechanisms that drive cancer development.

Top news of the day from across the health care landscape.

Combination treatments well tolerated amongst study participants with HIV-1 infection.

Proper dosing of Vorinostat can help expose latent HIV.

Memory T cell subtypes can be reactivated with current immunotherapy.

Subcutaneous belimumab (Benlysta) is a human monoclonal antibody that treats active, autoantibody-positive systemic lupus erythematosus.

Sanofi lawsuit delays emergence of follow-on biologic of insulin glargine injection for type 2 diabetes.

Top news of the day from across the health care landscape.

Renflexis is indicated for the same inflammatory conditions as reference drug infliximab.

Renflexis is a biosimilar of Remicade, which treats inflammatory conditions, including Crohn’s disease, rheumatoid arthritis, and psoriatic arthritis.

A combination of doxorubicin plus an aldose reductase inhibitor prevented cardiotoxicity in patients with colon cancer.

Potential treatment for primary progressive multiple sclerosis is an oral pill consisting of pharmaceutical formulations of purified THC and CBD.

Enzyme acts as an epigenetic checkpoint of T cell function to treat cancer.

Novel pathogen-associated molecular pattern drug combined with checkpoint inhibitor also evaluated in non small cell lung cancer.

Involving patients in the decision-making process can improve multiple sclerosis treatment adherence and overall quality-of-life.

A look at the top stories in pharmacy last week.

Top news of the day from across the healthcare landscape.